852 852 Pill - gray capsule/oblong, 16mm
Pill with imprint 852 852 is Gray, Capsule/Oblong and has been identified as Minocycline Hydrochloride 75 mg. It is supplied by Caraco Pharmaceutical Laboratories, Ltd.
Minocycline is used in the treatment of Bacterial Infection; Acne; Actinomycosis; Bartonellosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 852 852
Minocycline Hydrochloride
- Imprint
- 852 852
- Strength
- 75 mg
- Color
- Gray
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Caraco Pharmaceutical Laboratories, Ltd.
- National Drug Code (NDC)
- 57664-0852
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
povidone,
sodium starch glycolate type A potato,
magnesium stearate,
gelatin,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
ferrosoferric oxide,
shellac,
silicon dioxide,
titanium dioxide,
propylene glycol
Note: Inactive ingredients may vary.
Related images for "852 852"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (563)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline (Oral) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Solodyn, Dynacin, Minolira, ... +2 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minolira, Minocin for Injection, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.